Mankind Pharma Shares In Focus As InCred Initiates Coverage, Eyes 11% Upside — Check Target Price
InCred has set a target price of Rs 2,821 on Mankind Pharma stock, marking an upside of 11%.
open_in_new
open_in_new
Read Full Article on NDTV Profit
Original Article
Published on NDTV Profit
● Neutral
Source: NDTV Profit
open_in_new